BCWORLD PHARM. Co. Ltd
BCWORLD PHARM. Co., Ltd. operates as a pharmaceutical company in South Korea. The company provides products in various therapeutic areas comprising musculoskeletal system, digestive system, circulatory machine, central nervous system, adrenocorticosteroids, narcotic analgesics, erectile dysfunction treatment, wellbeing injection, diuretic, antitussive expectorant, vaginitis treatment, anti-tuberc… Read more
Market Cap & Net Worth: BCWORLD PHARM. Co. Ltd (200780)
BCWORLD PHARM. Co. Ltd (KQ:200780) has a market capitalization of $34.56 Million (₩50.61 Billion) as of March 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #25569 globally and #1586 in its home market, demonstrating a -7.30% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BCWORLD PHARM. Co. Ltd's stock price ₩4950.00 by its total outstanding shares 10223633 (10.22 Million).
BCWORLD PHARM. Co. Ltd Market Cap History: 2015 to 2026
BCWORLD PHARM. Co. Ltd's market capitalization history from 2015 to 2026. Data shows change from $164.99 Million to $34.56 Million (-13.43% CAGR).
Index Memberships
BCWORLD PHARM. Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$166.01 Billion | 0.01% | #833 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$166.01 Billion | 0.01% | #833 of 1384 |
Weight: BCWORLD PHARM. Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
BCWORLD PHARM. Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BCWORLD PHARM. Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
BCWORLD PHARM. Co. Ltd's market cap is 0.00 times its annual revenue
0.84x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $164.99 Million | $41.41 Billion | $6.33 Billion | 0.00x | 0.03x |
| 2016 | $139.60 Million | $45.66 Billion | $6.47 Billion | 0.00x | 0.02x |
| 2017 | $135.26 Million | $50.21 Billion | $8.08 Billion | 0.00x | 0.02x |
| 2018 | $135.89 Million | $55.11 Billion | $8.68 Billion | 0.00x | 0.02x |
| 2019 | $97.13 Million | $51.73 Billion | $6.06 Billion | 0.00x | 0.02x |
| 2020 | $159.34 Million | $56.93 Billion | $4.66 Billion | 0.00x | 0.03x |
| 2021 | $107.69 Million | $62.08 Billion | -$1.84 Billion | 0.00x | N/A |
| 2022 | $58.23 Million | $72.70 Billion | $281.30 Million | 0.00x | 0.21x |
| 2023 | $45.11 Million | $75.11 Billion | $2.63 Billion | 0.00x | 0.02x |
| 2024 | $32.61 Million | $74.81 Billion | -$4.43 Billion | 0.00x | N/A |
Competitor Companies of 200780 by Market Capitalization
Companies near BCWORLD PHARM. Co. Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to BCWORLD PHARM. Co. Ltd by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #15 globally with a market cap of $883.37 Billion USD.
- Johnson & Johnson (NYSE:JNJ): Ranked #18 globally with a market cap of $574.95 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #29 globally with a market cap of $390.88 Billion USD.
- AstraZeneca PLC (NASDAQ:AZN): Ranked #46 globally with a market cap of $296.35 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #15 | Eli Lilly and Company | NYSE:LLY | $883.37 Billion | $989.12 |
| #18 | Johnson & Johnson | NYSE:JNJ | $574.95 Billion | $243.19 |
| #29 | AbbVie Inc | NYSE:ABBV | $390.88 Billion | $221.45 |
| #46 | AstraZeneca PLC | NASDAQ:AZN | $296.35 Billion | $192.01 |
BCWORLD PHARM. Co. Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, BCWORLD PHARM. Co. Ltd's market cap moved from $164.99 Million to $ 34.56 Million, with a yearly change of -13.43%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩34.56 Million | -10.16% |
| 2025 | ₩38.47 Million | +17.99% |
| 2024 | ₩32.61 Million | -27.71% |
| 2023 | ₩45.11 Million | -22.54% |
| 2022 | ₩58.23 Million | -45.93% |
| 2021 | ₩107.69 Million | -32.41% |
| 2020 | ₩159.34 Million | +64.05% |
| 2019 | ₩97.13 Million | -28.53% |
| 2018 | ₩135.89 Million | +0.47% |
| 2017 | ₩135.26 Million | -3.11% |
| 2016 | ₩139.60 Million | -15.39% |
| 2015 | ₩164.99 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of BCWORLD PHARM. Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $34.56 Million USD |
| MoneyControl | $34.56 Million USD |
| MarketWatch | $34.56 Million USD |
| marketcap.company | $34.56 Million USD |
| Reuters | $34.56 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.